HomeCompareNHHS vs PFE

NHHS vs PFE: Dividend Comparison 2026

NHHS yields 108.11% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $4.9K in total portfolio value· pulled ahead in Year 10
10 years
NHHS
NHHS
● Live price
108.11%
Share price
$1.85
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.7K
Annual income
$23.96
Full NHHS calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NHHS vs PFE

📍 PFE pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHHSPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHHS + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHHS pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHHS
Annual income on $10K today (after 15% tax)
$9,189.19/yr
After 10yr DRIP, annual income (after tax)
$20.37/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,299.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHHS + PFE for your $10,000?

NHHS: 50%PFE: 50%
100% PFE50/50100% NHHS
Portfolio after 10yr
$47.1K
Annual income
$13,141.34/yr
Blended yield
27.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NHHS
No analyst data
Altman Z
-0.7
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHHS buys
0
PFE buys
0
No recent congressional trades found for NHHS or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHHSPFE
Forward yield108.11%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$44.7K$49.6K
Annual income after 10y$23.96$26,258.71
Total dividends collected$14.8K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NHHS vs PFE ($10,000, DRIP)

YearNHHS PortfolioNHHS Income/yrPFE PortfolioPFE Income/yrGap
1$16,105$5,405.41$9,153$693.39+$7.0KNHHS
2$21,301$4,068.05$8,593$849.25+$12.7KNHHS
3$25,306$2,514.19$8,336$1,066.78+$17.0KNHHS
4$28,473$1,395.76$8,437$1,384.80+$20.0KNHHS
5$31,200$733.86$9,013$1,875.40+$22.2KNHHS
6$33,760$375.77$10,306$2,680.72+$23.5KNHHS
7$36,313$190.00$12,820$4,101.38+$23.5KNHHS
8$38,951$95.50$17,673$6,826.70+$21.3KNHHS
9$41,725$47.87$27,543$12,591.86+$14.2KNHHS
10← crossover$44,670$23.96$49,560$26,258.71$4.9KPFE

NHHS vs PFE: Complete Analysis 2026

NHHSStock

NorthStar Healthcare was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which NorthStar Healthcare defines as assisted living, memory care, skilled nursing and independent living facilities and continuing care retirement communities. NorthStar Healthcare also invests in other healthcare property types, including medical office buildings, hospitals, rehabilitation facilities and ancillary healthcare services businesses. NorthStar Healthcare's investments are predominantly in the United States, but it also selectively makes international investments. NorthStar Healthcare is externally managed and has no employees. NorthStar Healthcare is sponsored by Colony Capital, Inc. (NYSE: CLNY). NorthStar Healthcare's advisor, CNI NSHC Advisors, LLC, is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement.

Full NHHS Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NHHS vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHHS vs SCHDNHHS vs JEPINHHS vs ONHHS vs KONHHS vs MAINNHHS vs JNJNHHS vs MRKNHHS vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.